Stay updated on T-DXd in HER2 Expressing Tumors Clinical Trial
Sign up to get notified when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.

Latest updates to the T-DXd in HER2 Expressing Tumors Clinical Trial page
- Check6 days agoChange DetectedThis update shows the site/versioning revision to v3.6.6. It indicates a maintenance release that does not modify the study information presented on the page.SummaryDifference0.0%

- Check13 days agoChange DetectedThe study identifiers section now includes a 2023 U.S. NIH Grant/Contract entry, reflecting NIH funding attribution for this trial.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new build/version of the site. This typically reflects maintenance or small fixes and does not change the study details shown on the page.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page now displays Revision: v3.6.4, updating the site version tag from v3.6.3 to v3.6.4, which reflects a backend/template update rather than changes to trial details.SummaryDifference0.0%

- Check56 days agoChange DetectedRecent updates were added to the study record with July 2026 timestamps, and older April 2026 timestamps were removed. This alters the visible update timeline and indicates renewed record-keeping activity for the study.SummaryDifference0.1%

- Check63 days agoChange DetectedThe revision tag at the bottom of the page updated from v3.6.2 to v3.6.3, indicating a new page release or update rather than a change to study details. This is a metadata-level update and does not alter the study content.SummaryDifference0.0%

Stay in the know with updates to T-DXd in HER2 Expressing Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.